Medindia LOGIN REGISTER
Medindia
Advertisement

New Insights into Anti-rheumatic Drugs

by Colleen Fleiss on May 12, 2018 at 11:18 PM
New Insights into Anti-rheumatic Drugs

Stopping tumor necrosis factor inhibitors in patients with stable low disease activity, on average, was associated with a cost saving of 7,133, a loss of 0.022 quality-adjusted life years, and an increase of 0.41 arthritis flares per patient per year, reveals study published in Arthritis & Rheumatology.

In the study, "The subpopulation of patients receiving biological disease modifying anti-rheumatic drugs including tumor necrosis factor inhibitors... has increased over time and accounted for up to 20% of the population of rheumatoid arthritis patients in various Western healthcare systems," the authors wrote.

Advertisement


Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joints and the surrounding tissues. It is an autoimmune disease.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Could Baricitinib, an Arthritis Drug, Treat Type 1 Diabetes?
The drug baricitinib can safely and effectively maintain the body's natural insulin production while inhibiting the advancement of Type 1 diabetes.
Anti-Obesity Drugs' Impact on Osteoarthritis Survival
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Insights into Anti-rheumatic Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests